OUTCOME OF METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS TREATED BY ANTI-PD-1 THERAPY IN EXPANDED ACCESS PROGRAM: CLINICAL EFFICACY AND POTENTIAL BIOMARKERS FOR NIVOLUMAB THERAPY | Sayapina | Malignant tumours

Malignant tumours
Zlokačestvennye opuholi

ISSN 2224-5057 (Print)
ISSN 2587-6813 (Online)

eng | рус

Preview

Malignant tumours

Advanced search

Archives

Download this PDF file

For citations:

Sayapina M.S., Savyolov N.A., Lyubimova N.V., Timofeev Yu.S., Nosov D.A. OUTCOME OF METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS TREATED BY ANTI-PD-1 THERAPY IN EXPANDED ACCESS PROGRAM: CLINICAL EFFICACY AND POTENTIAL BIOMARKERS FOR NIVOLUMAB THERAPY. Malignant tumours. 2018;8(3):31-38. (In Russ.) https://doi.org/10.18027/2224-5057-2018-8-3-31-38

Views PDF (Rus): 895

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2224-5057 (Print)
ISSN 2587-6813 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Nosov D.A.

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

M. S. Sayapina
N.N. Blokhin Russian Cancer Research Center.
Russian Federation

Mariya S. Sayapina, MD, PhD Med, post-graduate student (2013–2016) of the Department of Clinical Pharmacology and Chemotherapy.

Moscow.

N. A. Savyolov
Moscow City Oncological Hospital No. 62 of the Moscow Healthcare Depar tment.
Russian Federation

Nikita A. Savyolov, MD, PhD Med, Head of the Department of Pathomorphology.

Moscow.

N. V. Lyubimova
N.N. Blokhin Russian Cancer Research Center.
Russian Federation

Nina V. Lyubimova, MD, DSc Med, Professor, Leading Researcher, Laboratory of Clinical Biochemistry.

Moscow.

Yu. S. Timofeev
N.N. Blokhin Russian Cancer Research Center.
Russian Federation

Yuriy S. Timofeev, MD, PhD Med, Leading Researcher, Laboratory of Clinical Biochemistry.

Moscow.

D. A. Nosov
Central Clinical Hospital of the Presidential Administration of the Russian Federation.
Russian Federation

Dmitriy A. Nosov, MD, DSc Med, Professor, Head of the Department of Antitumor Treatment.

Moscow.

Notifications